WallStreetZenWallStreetZen

NASDAQ: DMTK
Dermtech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DMTK past revenue growth

How has DMTK's revenue growth performed historically?
Company
22.64%
Industry
10.63%
Market
21.8%
DMTK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DMTK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DMTK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DMTK earnings and revenue history

Current Revenue
$14.5M
Current Earnings
-$116.7M
Current Profit Margin
-803.7%

DMTK Return on Equity

Current Company
-69.7%
Current Industry
421.6%
Current Market
188%
DMTK's Return on Equity (-69.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DMTK announces earnings.

DMTK Return on Assets

Current Company
-54.8%
Current Industry
6.6%
DMTK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DMTK Return on Capital Employed

Current Company
-62.59%
Current Industry
10.9%
DMTK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DMTK vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DMTK$14.52M-$112.22M-$116.68M+56.15%N/A
BVS$516.70M-$108.32M-$127.14M+27.05%N/A
DRIO$27.66M-$57.47M-$63.84M+39.85%N/A
VNRX$306.39k-$28.91M-$30.27M+256.73%N/A
PRE$275.76MN/A-$190.45M+133.77%N/A
View Top Diagnostic & Research Stocks

DMTK earnings dates

Next earnings date
May 1, 2023

Dermtech Earnings & Revenue FAQ

What were DMTK's earnings last quarter?

On Invalid Date, Dermtech (NASDAQ: DMTK) reported Q4 2022 earnings per share (EPS) of -$0.93, up 5.68% year over year. Total Dermtech earnings for the quarter were -$28.22 million. In the same quarter last year, Dermtech's earnings per share (EPS) was -$0.88.

If you're new to stock investing, here's how to buy Dermtech stock.

What was DMTK's earnings growth in the past year?

As of Q1 2023, Dermtech's earnings has grown year over year. Dermtech's earnings in the past year totalled -$116.68 million.

What is DMTK's earnings date?

Dermtech's earnings date is Invalid Date. Add DMTK to your watchlist to be reminded of DMTK's next earnings announcement.

What was DMTK's revenue last quarter?

On Invalid Date, Dermtech (NASDAQ: DMTK) reported Q4 2022 revenue of $2.99 million up 5.4% year over year. In the same quarter last year, Dermtech's revenue was $3.17 million.

What was DMTK's revenue growth in the past year?

As of Q1 2023, Dermtech's revenue has grown 22.64% year over year. This is 12.01 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Dermtech's revenue in the past year totalled $14.52 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.